GlassScriptPhysician profile
Adam Harrison Beall
NPI 1275807026
$19,577.22
in general payments reported to CMS, 2019-2025
43 companies · $340 in 2025
The $340 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $523 · 2020: $11K · 2021: $1,950 · 2022: $173 · 2023: $147 · 2024: $5,420 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Food and Beverage: $2,195 · Travel and Lodging: $1,203 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Food and Beverage | $2,194.90 |
| Travel and Lodging | $1,203.11 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $16,049.20 | 2019-2024 | Da Vinci Surgical System |
| Allergan, INC. | $1,790.85 | 2021 | |
| Boston Scientific Corporation | $146.28 | 2024-2025 | Spyglass Discover |
| Takeda Pharmaceuticals U.S.A., INC. | $144.44 | 2020-2024 | Eohilia |
| Smith+Nephew, INC. | $116.05 | 2019-2024 | Collagenase Santyl, Stravix |
| Ethicon US, LLC | $110.60 | 2020-2021 | |
| Cook Medical LLC | $109.88 | 2024 | Zilver Ptx |
| Merck Sharp & Dohme LLC | $94.74 | 2019-2025 | Keytruda, Lynparza |
| Becton, Dickinson and Company | $88.84 | 2024 | |
| Heron Therapeutics, INC. | $74.96 | 2022 | |
| Molli Surgical (US) INC | $64.35 | 2023 | |
| Davol INC. | $57.64 | 2024-2025 | Phasix Mesh |
| Polynovo North America LLC | $54.98 | 2024 | Novosorb Btm |
| Ferring Pharmaceuticals INC. | $49.18 | 2024 | Rebyota |
| Eagle Pharmaceuticals, INC. | $41.00 | 2023-2024 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $39.39 | 2019-2024 | Irrisept |
| Teleflex LLC | $34.19 | 2025 | Quikclot, Titan Sgs Bailout Chuck |
| Baxter Healthcare | $32.65 | 2023 | Seprafilm |
| Merit Medical Systems INC | $30.12 | 2024-2025 | Savi Scout |
| Pacira Pharmaceuticals Incorporated | $29.92 | 2019-2025 | Exparel |
| Solventum Corporation | $29.55 | 2024-2025 | Activ.A.C., Prevena |
| Axonics, INC. | $29.09 | 2024 | Bulkamid, Axonics |
| Misonix INC | $27.36 | 2019-2020 | |
| Kci USA, INC. | $27.07 | 2019-2022 | |
| Convatec INC. | $23.26 | 2025 | |
| W. L. Gore & Associates, INC. | $22.67 | 2019 | |
| Abbvie INC. | $22.21 | 2023 | Dalvance |
| Acera Surgical, INC. | $21.84 | 2025 | Restrata Wound Matrix |
| Shire North American Group INC | $21.77 | 2019 | |
| Medtronic, INC. | $19.54 | 2025 | Progrip |
| Endogastric Solutions, INC | $19.11 | 2019 | |
| Medela LLC | $15.88 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $15.26 | 2025 | |
| Lucid Diagnostics INC. | $15.03 | 2025 | |
| Osiris Therapeutics INC. | $14.77 | 2019 | |
| Tela Bio, INC. | $14.61 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kerecis Limited | $14.25 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Octapharma USA, INC. | $14.16 | 2025 | Fibryga |
| Tetraphase Pharmaceuticals, INC. | $12.22 | 2019 | |
| Ambu INC. | $11.81 | 2022 | |
| Covidien LP | $11.68 | 2019 | |
| Thd America, INC. | $8.56 | 2025 | |
| Next Science LLC | $6.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Beall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.